• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidones

Recent Advances in the Study of 5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS: 7248-96-6)

5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS: 7248-96-6) is a pyrimidine derivative that has garnered significant attention in recent years due to its potential applications in pharmaceutical and chemical research. This compound, characterized by its unique structural features, has been the subject of various studies aimed at exploring its synthesis, biological activity, and therapeutic potential. The following sections provide a comprehensive overview of the latest research findings related to this compound.

Recent studies have focused on the synthesis and optimization of 5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione. Researchers have developed novel synthetic routes to improve yield and purity, leveraging advanced techniques such as microwave-assisted synthesis and green chemistry approaches. These methods have demonstrated significant advantages in terms of efficiency and environmental sustainability, making them highly relevant for industrial-scale production.

In the realm of biological activity, 5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione has shown promising results in preclinical studies. Its mechanism of action appears to involve modulation of key enzymatic pathways, particularly those related to inflammation and oxidative stress. Recent in vitro and in vivo studies have highlighted its potential as an anti-inflammatory and neuroprotective agent, with some reports suggesting its efficacy in models of neurodegenerative diseases.

Further investigations into the pharmacokinetics and pharmacodynamics of this compound have revealed favorable absorption and distribution profiles. However, challenges remain in optimizing its bioavailability and minimizing potential side effects. Researchers are actively exploring formulation strategies, including nanoparticle-based delivery systems, to enhance its therapeutic index.

The structural versatility of 5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione has also spurred interest in its use as a building block for the development of novel drug candidates. Several derivatives have been synthesized and evaluated for their biological activity, with some showing enhanced potency and selectivity compared to the parent compound. These findings underscore the potential of this scaffold in drug discovery programs.

In conclusion, the ongoing research on 5-ethoxy-1,2,3,4-tetrahydropyrimidine-2,4-dione (CAS: 7248-96-6) highlights its multifaceted potential in pharmaceutical and chemical applications. While significant progress has been made, further studies are needed to fully elucidate its therapeutic potential and address existing challenges. The compound's unique properties and promising preclinical data make it a compelling subject for future research endeavors.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)